Follow
Wolfram Hoetzenecker
Wolfram Hoetzenecker
Kantonsspital St. Gallen, Schweiz
Verified email at usz.ch
Title
Cited by
Cited by
Year
Melanoma cell-intrinsic PD-1 receptor functions promote tumor growth
S Kleffel, C Posch, SR Barthel, H Mueller, C Schlapbach, E Guenova, ...
Cell 162 (6), 1242-1256, 2015
6622015
Cellular and molecular immunologic mechanisms in patients with atopic dermatitis
T Werfel, JP Allam, T Biedermann, K Eyerich, S Gilles, E Guttman-Yassky, ...
Journal of allergy and clinical immunology 138 (2), 336-349, 2016
5892016
Alpha‐Gal on bioprostheses: xenograft immune response in cardiac surgery
K Z. Konakci, B Bohle, R Blumer, W Hoetzenecker, G Roth, B Moser, ...
European journal of clinical investigation 35 (1), 17-23, 2005
2872005
Virus-induced senescence is a driver and therapeutic target in COVID-19
S Lee, Y Yu, J Trimpert, F Benthani, M Mairhofer, P Richter-Pechanska, ...
Nature 599 (7884), 283-289, 2021
2322021
Multifocal epithelial tumors and field cancerization from loss of mesenchymal CSL signaling
B Hu, E Castillo, L Harewood, P Ostano, A Reymond, R Dummer, ...
Cell 149 (6), 1207-1220, 2012
2272012
Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation
MG Procopio, C Laszlo, D Al Labban, DE Kim, P Bordignon, SH Jo, ...
Nature cell biology 17 (9), 1193-1204, 2015
2102015
Interleukin 23 expression in pyoderma gangrenosum and targeted therapy with ustekinumab
E Guenova, A Teske, B Fehrenbacher, S Hoerber, A Adamczyk, ...
Archives of dermatology 147 (10), 1203-1205, 2011
2012011
ROS-induced ATF3 causes susceptibility to secondary infections during sepsis-associated immunosuppression
W Hoetzenecker, B Echtenacher, E Guenova, K Hoetzenecker, ...
Nature medicine, 2011
1932011
IL-4 abrogates TH17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells
E Guenova, Y Skabytska, W Hoetzenecker, G Weindl, K Sauer, M Tham, ...
Proceedings of the National Academy of Sciences 112 (7), 2163-2168, 2015
1842015
Adverse cutaneous drug eruptions: current understanding
W Hoetzenecker, M Nägeli, ET Mehra, AN Jensen, I Saulite, ...
Seminars in immunopathology 38, 75-86, 2016
1732016
The Role of Malassezia spp. in Atopic Dermatitis
M Glatz, PP Bosshard, W Hoetzenecker, P Schmid-Grendelmeier
Journal of clinical medicine 4 (6), 1217-1228, 2015
1652015
A miR‐34a‐SIRT6 axis in the squamous cell differentiation network
K Lefort, Y Brooks, P Ostano, M Cario‐André, V Calpini, ...
The EMBO journal 32 (16), 2248-2263, 2013
1492013
Corticosteroids but not pimecrolimus affect viability, maturation and immune function of murine epidermal Langerhans cells
W Hoetzenecker, JG Meingassner, R Ecker, G Stingl, A Stuetz, ...
Journal of investigative dermatology 122 (3), 673-684, 2004
1392004
Guidelines for diagnosis, prevention, and treatment of hand eczema
JP Thyssen, MLA Schuttelaar, JH Alfonso, KE Andersen, ...
Contact Dermatitis 86 (5), 357-378, 2022
1302022
Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis.
W Hoetzenecker, R Ecker, T Kopp, A Stuetz, G Stingl, A Elbe-Bürger
The Journal of allergy and clinical immunology 115 (6), 1276, 2005
1032005
Basal serum tryptase as risk assessment for severe Hymenoptera sting reactions in elderly
E Guenova, T Volz, M Eichner, W Hoetzenecker, U Caroli, G Griesinger, ...
Allergy 65 (7), 919-923, 2010
972010
Global Allergy Forum and 3rd Davos Declaration 2015: Atopic dermatitis/Eczema: challenges and opportunities toward precision medicine
T Bieber, C Akdis, R Lauener, C Traidl‐Hoffmann, ...
Allergy 71 (5), 588-592, 2016
732016
Efficacy of bath psoralen plus ultraviolet A (PUVA) vs. system PUVA in psoriasis: a prospective, open, randomized, multicentre study
M Berneburg, T Herzinger, J Rampf, W Hoetzenecker, E Guenova, ...
British Journal of Dermatology 169 (3), 704-708, 2013
622013
Brentuximab as a treatment for CD30+ mycosis fungoides and Sézary syndrome
T Mehra, K Ikenberg, RM Moos, R Benz, G Nair, U Schanz, ...
JAMA dermatology 151 (1), 73-77, 2015
582015
Molecular characteristics suggest an effector function of palisade endings in extraocular muscles
KZ Konakci, J Streicher, W Hoetzenecker, MJF Blumer, JR Lukas, ...
Investigative ophthalmology & visual science 46 (1), 155-165, 2005
562005
The system can't perform the operation now. Try again later.
Articles 1–20